Clinical trial
Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury…
NCT00060450 · Mallinckrodt, Industry · Terminated
Key facts
| NCT number | NCT00060450 |
|---|---|
| Title | Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation |
| Official title | Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemia-Reperfusion Injury |
| Intervention type | Drug |
| Interventions | nitric oxide for inhalation, Placebo |
| Enrollment | 84 |
| Start date | Aug 1, 2001 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | May 7, 2003 |
| Last update posted | Sep 9, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: